(DAVA) Endava - Overview
Exchange: NYSE •
Country: United Kingdom •
Currency: USD •
Type: Common Stock •
ISIN: US29260V1052
Stock: Digital Strategy, Product Development, Engineering, Data, Cloud
Total Rating 28
Risk 88
Buy Signal -0.41
| Risk 5d forecast | |
|---|---|
| Volatility | 66.0% |
| Relative Tail Risk | -13.5% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.65 |
| Alpha | -101.91 |
| Character TTM | |
|---|---|
| Beta | 1.379 |
| Beta Downside | 1.410 |
| Drawdowns 3y | |
|---|---|
| Max DD | 94.33% |
| CAGR/Max DD | -0.63 |
EPS (Earnings per Share)
Revenue
Risks
Technicals:
choppy
Description: DAVA Endava March 04, 2026
Endava provides technology services across North America, Europe, and the UK, specializing in digital transformation and IT consulting. The companys business model focuses on delivering a broad range of services from strategy and design to engineering and managed services.
Key service areas include digital product acceleration, advisory, delivery, digital engineering, data and AI, and modern managed services. This comprehensive approach is typical for IT consulting firms aiming to capture various stages of client digital initiatives.
Endava serves diverse sectors, including healthcare, finance, retail, and automotive, demonstrating a wide client base. The IT consulting sector is characterized by project-based work and the need for specialized technical expertise.
For more detailed financial analysis, ValueRay offers in-depth company insights.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: -2.86m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 0.88 > 1.0 |
| NWC/Revenue: 20.82% < 20% (prev 16.07%; Δ 4.75% < -1%) |
| CFO/TA 0.06 > 3% & CFO 54.7m > Net Income -2.86m |
| Net Debt (213.5m) to EBITDA (57.5m): 3.71 < 3 |
| Current Ratio: 2.39 > 1.5 & < 3 |
| Outstanding Shares: last quarter (52.9m) vs 12m ago -11.32% < -2% |
| Gross Margin: 23.40% > 18% (prev 0.24%; Δ 2315 % > 0.5%) |
| Asset Turnover: 77.75% > 50% (prev 77.45%; Δ 0.31% > 0%) |
| Interest Coverage Ratio: 2.34 > 6 (EBITDA TTM 57.5m / Interest Expense TTM 8.26m) |
Altman Z'' 4.91
| A: 0.17 (Total Current Assets 265.8m - Total Current Liabilities 111.4m) / Total Assets 926.7m |
| B: 0.65 (Retained Earnings 598.5m / Total Assets 926.7m) |
| C: 0.02 (EBIT TTM 19.3m / Avg Total Assets 953.7m) |
| D: 1.51 (Book Value of Equity 545.3m / Total Liabilities 362.3m) |
| Altman-Z'' Score: 4.91 = AAA |
Beneish M -3.09
| DSRI: 1.01 (Receivables 197.3m/200.1m, Revenue 741.5m/759.4m) |
| GMI: 1.03 (GM 23.40% / 24.12%) |
| AQI: 0.98 (AQ_t 0.65 / AQ_t-1 0.67) |
| SGI: 0.98 (Revenue 741.5m / 759.4m) |
| TATA: -0.06 (NI -2.86m - CFO 54.7m) / TA 926.7m) |
| Beneish M-Score: -3.09 (Cap -4..+1) = AA |
What is the price of DAVA shares?
As of March 05, 2026, the stock is trading at USD 5.30 with a total of 572,818 shares traded.
Over the past week, the price has changed by +11.58%, over one month by -4.85%, over three months by -18.21% and over the past year by -77.16%.
Over the past week, the price has changed by +11.58%, over one month by -4.85%, over three months by -18.21% and over the past year by -77.16%.
Is DAVA a buy, sell or hold?
Endava has received a consensus analysts rating of 3.92.
Therefore, it is recommended to buy DAVA.
- StrongBuy: 5
- Buy: 1
- Hold: 6
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the DAVA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 9.2 | 73.8% |
| Analysts Target Price | 9.2 | 73.8% |
DAVA Fundamental Data Overview March 03, 2026
Market Cap GBP = 189.4m (254.3m USD * 0.7451 USD.GBP)
P/E Trailing = 20.3478
P/E Forward = 4.2974
P/S = 0.3418
P/B = 0.3207
P/EG = 0.5969
Revenue TTM = 741.5m GBP
EBIT TTM = 19.3m GBP
EBITDA TTM = 57.5m GBP
Long Term Debt = 180.9m GBP (from longTermDebt, last fiscal year)
Short Term Debt = 13.8m GBP (from shortTermDebt, last quarter)
Debt = 281.8m GBP (from shortLongTermDebtTotal, last quarter)
Net Debt = 213.5m GBP (from netDebt column, last quarter)
Enterprise Value = 402.8m GBP (189.4m + Debt 281.8m - CCE 68.5m)
Interest Coverage Ratio = 2.34 (Ebit TTM 19.3m / Interest Expense TTM 8.26m)
EV/FCF = 9.93x (Enterprise Value 402.8m / FCF TTM 40.6m)
FCF Yield = 10.07% (FCF TTM 40.6m / Enterprise Value 402.8m)
FCF Margin = 5.47% (FCF TTM 40.6m / Revenue TTM 741.5m)
Net Margin = -0.39% (Net Income TTM -2.86m / Revenue TTM 741.5m)
Gross Margin = 23.40% ((Revenue TTM 741.5m - Cost of Revenue TTM 568.0m) / Revenue TTM)
Gross Margin QoQ = 17.27% (prev 21.14%)
Tobins Q-Ratio = 0.43 (Enterprise Value 402.8m / Total Assets 926.7m)
Interest Expense / Debt = 1.50% (Interest Expense 4.22m / Debt 281.8m)
Taxrate = 12.03% (2.90m / 24.1m)
NOPAT = 17.0m (EBIT 19.3m * (1 - 12.03%))
Current Ratio = 2.39 (Total Current Assets 265.8m / Total Current Liabilities 111.4m)
Debt / Equity = 0.50 (Debt 281.8m / totalStockholderEquity, last quarter 564.4m)
Debt / EBITDA = 3.71 (Net Debt 213.5m / EBITDA 57.5m)
Debt / FCF = 5.26 (Net Debt 213.5m / FCF TTM 40.6m)
Total Stockholder Equity = 590.4m (last 4 quarters mean from totalStockholderEquity)
RoA = -0.30% (Net Income -2.86m / Total Assets 926.7m)
RoE = -0.48% (Net Income TTM -2.86m / Total Stockholder Equity 590.4m)
RoCE = 2.50% (EBIT 19.3m / Capital Employed (Equity 590.4m + L.T.Debt 180.9m))
RoIC = 2.21% (NOPAT 17.0m / Invested Capital 769.3m)
WACC = 5.20% (E(189.4m)/V(471.3m) * Re(10.99%) + D(281.8m)/V(471.3m) * Rd(1.50%) * (1-Tc(0.12)))
Discount Rate = 10.99% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -5.01%
[DCF] Terminal Value 85.45% ; FCFF base≈38.1m ; Y1≈35.0m ; Y5≈31.3m
[DCF] Fair Price = 18.54 (EV 944.0m - Net Debt 213.5m = Equity 730.5m / Shares 39.4m; r=5.90% [WACC]; 5y FCF grow -10.11% → 2.90% )
EPS Correlation: -88.84 | EPS CAGR: -78.15% | SUE: -0.00 | # QB: 0
Revenue Correlation: -2.30 | Revenue CAGR: 1.92% | SUE: 0.03 | # QB: 0
EPS current Year (2026-06-30): EPS=0.82 | Chg7d=+0.036 | Chg30d=+0.031 | Revisions Net=+6 | Growth EPS=-27.8% | Growth Revenue=-4.2%
EPS next Year (2027-06-30): EPS=0.98 | Chg7d=+0.023 | Chg30d=+0.020 | Revisions Net=-1 | Growth EPS=+19.9% | Growth Revenue=+4.7%
[Analyst] Revisions Ratio: +0.75 (7 Up / 1 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 6.1% (Discount Rate 11.0% - Earnings Yield 4.9%)
[Growth] Growth Spread = -1.4% (Analyst 4.7% - Implied 6.1%)
P/E Trailing = 20.3478
P/E Forward = 4.2974
P/S = 0.3418
P/B = 0.3207
P/EG = 0.5969
Revenue TTM = 741.5m GBP
EBIT TTM = 19.3m GBP
EBITDA TTM = 57.5m GBP
Long Term Debt = 180.9m GBP (from longTermDebt, last fiscal year)
Short Term Debt = 13.8m GBP (from shortTermDebt, last quarter)
Debt = 281.8m GBP (from shortLongTermDebtTotal, last quarter)
Net Debt = 213.5m GBP (from netDebt column, last quarter)
Enterprise Value = 402.8m GBP (189.4m + Debt 281.8m - CCE 68.5m)
Interest Coverage Ratio = 2.34 (Ebit TTM 19.3m / Interest Expense TTM 8.26m)
EV/FCF = 9.93x (Enterprise Value 402.8m / FCF TTM 40.6m)
FCF Yield = 10.07% (FCF TTM 40.6m / Enterprise Value 402.8m)
FCF Margin = 5.47% (FCF TTM 40.6m / Revenue TTM 741.5m)
Net Margin = -0.39% (Net Income TTM -2.86m / Revenue TTM 741.5m)
Gross Margin = 23.40% ((Revenue TTM 741.5m - Cost of Revenue TTM 568.0m) / Revenue TTM)
Gross Margin QoQ = 17.27% (prev 21.14%)
Tobins Q-Ratio = 0.43 (Enterprise Value 402.8m / Total Assets 926.7m)
Interest Expense / Debt = 1.50% (Interest Expense 4.22m / Debt 281.8m)
Taxrate = 12.03% (2.90m / 24.1m)
NOPAT = 17.0m (EBIT 19.3m * (1 - 12.03%))
Current Ratio = 2.39 (Total Current Assets 265.8m / Total Current Liabilities 111.4m)
Debt / Equity = 0.50 (Debt 281.8m / totalStockholderEquity, last quarter 564.4m)
Debt / EBITDA = 3.71 (Net Debt 213.5m / EBITDA 57.5m)
Debt / FCF = 5.26 (Net Debt 213.5m / FCF TTM 40.6m)
Total Stockholder Equity = 590.4m (last 4 quarters mean from totalStockholderEquity)
RoA = -0.30% (Net Income -2.86m / Total Assets 926.7m)
RoE = -0.48% (Net Income TTM -2.86m / Total Stockholder Equity 590.4m)
RoCE = 2.50% (EBIT 19.3m / Capital Employed (Equity 590.4m + L.T.Debt 180.9m))
RoIC = 2.21% (NOPAT 17.0m / Invested Capital 769.3m)
WACC = 5.20% (E(189.4m)/V(471.3m) * Re(10.99%) + D(281.8m)/V(471.3m) * Rd(1.50%) * (1-Tc(0.12)))
Discount Rate = 10.99% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -5.01%
[DCF] Terminal Value 85.45% ; FCFF base≈38.1m ; Y1≈35.0m ; Y5≈31.3m
[DCF] Fair Price = 18.54 (EV 944.0m - Net Debt 213.5m = Equity 730.5m / Shares 39.4m; r=5.90% [WACC]; 5y FCF grow -10.11% → 2.90% )
EPS Correlation: -88.84 | EPS CAGR: -78.15% | SUE: -0.00 | # QB: 0
Revenue Correlation: -2.30 | Revenue CAGR: 1.92% | SUE: 0.03 | # QB: 0
EPS current Year (2026-06-30): EPS=0.82 | Chg7d=+0.036 | Chg30d=+0.031 | Revisions Net=+6 | Growth EPS=-27.8% | Growth Revenue=-4.2%
EPS next Year (2027-06-30): EPS=0.98 | Chg7d=+0.023 | Chg30d=+0.020 | Revisions Net=-1 | Growth EPS=+19.9% | Growth Revenue=+4.7%
[Analyst] Revisions Ratio: +0.75 (7 Up / 1 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 6.1% (Discount Rate 11.0% - Earnings Yield 4.9%)
[Growth] Growth Spread = -1.4% (Analyst 4.7% - Implied 6.1%)